Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	hexosyltransferase activity	ABO GCNT3 DPY19L2 DPY19L1 B3GALNT2 B3GALT5 TMTC2 GCNT2 UGT2B10	7.68e-05	211	168	9	GO:0016758
GeneOntologyMolecularFunction	glycosyltransferase activity	ABO GCNT3 DPY19L2 DPY19L1 GLT1D1 B3GALNT2 B3GALT5 TMTC2 GCNT2 UGT2B10	1.69e-04	288	168	10	GO:0016757
GeneOntologyMolecularFunction	RNA uridylyltransferase activity	TUT4 TUT7	2.10e-04	3	168	2	GO:0050265
GeneOntologyMolecularFunction	N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity	GCNT3 GCNT2	2.10e-04	3	168	2	GO:0008109
Domain	Sortilin_C	SORCS1 SORCS3 SORL1	6.93e-06	5	167	3	PF15901
Domain	Sortilin-Vps10	SORCS1 SORCS3 SORL1	6.93e-06	5	167	3	PF15902
Domain	VPS10	SORCS1 SORCS3 SORL1	6.93e-06	5	167	3	IPR006581
Domain	Sortilin_N	SORCS1 SORCS3 SORL1	6.93e-06	5	167	3	IPR031778
Domain	Sortilin_C	SORCS1 SORCS3 SORL1	6.93e-06	5	167	3	IPR031777
Domain	VPS10	SORCS1 SORCS3 SORL1	6.93e-06	5	167	3	SM00602
Domain	ZnF_UBR1	UBR1 FBXO11 UBR3	2.39e-05	7	167	3	SM00396
Domain	ZF_UBR	UBR1 FBXO11 UBR3	2.39e-05	7	167	3	PS51157
Domain	zf-UBR	UBR1 FBXO11 UBR3	2.39e-05	7	167	3	PF02207
Domain	Znf_UBR	UBR1 FBXO11 UBR3	2.39e-05	7	167	3	IPR003126
Domain	Sialidases	SORCS1 SORCS3 SORL1	5.67e-05	9	167	3	IPR011040
Domain	PKD	SORCS1 TMEM130 SORCS3	1.10e-04	11	167	3	PS50093
Domain	PKD_dom	SORCS1 TMEM130 SORCS3	1.10e-04	11	167	3	IPR000601
Domain	-	SORCS1 TMEM130 SORCS3	1.10e-04	11	167	3	2.60.40.670
Domain	EGF	ATRN CNTNAP3B CNTNAP3 TECTA TENM3 MEGF9 TENM1 CNTNAP4 SORL1	2.71e-04	235	167	9	SM00181
Domain	LAM_G_DOMAIN	CNTNAP3B CNTNAP3 CNTNAP4 USH2A	3.59e-04	38	167	4	PS50025
Domain	EGF-like_dom	ATRN CNTNAP3B CNTNAP3 TECTA TENM3 MEGF9 TENM1 CNTNAP4 SORL1	4.14e-04	249	167	9	IPR000742
Domain	Laminin_G_2	CNTNAP3B CNTNAP3 CNTNAP4 USH2A	4.38e-04	40	167	4	PF02210
Domain	Tox-GHH_dom	TENM3 TENM1	4.71e-04	4	167	2	IPR028916
Domain	Dpy19	DPY19L2 DPY19L1	4.71e-04	4	167	2	PF10034
Domain	Tox-GHH	TENM3 TENM1	4.71e-04	4	167	2	PF15636
Domain	Dpy-19/Dpy-19-like	DPY19L2 DPY19L1	4.71e-04	4	167	2	IPR018732
Domain	Ten_N	TENM3 TENM1	4.71e-04	4	167	2	IPR009471
Domain	Ten_N	TENM3 TENM1	4.71e-04	4	167	2	PF06484
Domain	TENEURIN_N	TENM3 TENM1	4.71e-04	4	167	2	PS51361
Domain	LamG	CNTNAP3B CNTNAP3 CNTNAP4 USH2A	6.33e-04	44	167	4	SM00282
Domain	fn3	DCC PTPRD CNTN5 USH2A IL23R LRIT1 SORL1	6.44e-04	162	167	7	PF00041
Domain	YD	TENM3 TENM1	7.81e-04	5	167	2	IPR006530
Domain	FA58C	CNTNAP3B CNTNAP3 CNTNAP4	8.30e-04	21	167	3	SM00231
Domain	FA58C_3	CNTNAP3B CNTNAP3 CNTNAP4	8.30e-04	21	167	3	PS50022
Domain	FA58C_1	CNTNAP3B CNTNAP3 CNTNAP4	8.30e-04	21	167	3	PS01285
Domain	FA58C_2	CNTNAP3B CNTNAP3 CNTNAP4	8.30e-04	21	167	3	PS01286
Domain	F5_F8_type_C	CNTNAP3B CNTNAP3 CNTNAP4	1.24e-03	24	167	3	PF00754
Domain	FA58C	CNTNAP3B CNTNAP3 CNTNAP4	1.24e-03	24	167	3	IPR000421
Domain	FN3	DCC PTPRD CNTN5 USH2A IL23R LRIT1 SORL1	1.40e-03	185	167	7	SM00060
Domain	PKD	SORCS1 SORCS3	1.62e-03	7	167	2	PF00801
Domain	G_CP_dom	GNL3L GNL3	1.62e-03	7	167	2	IPR030378
Domain	PAP_assoc	TUT4 TUT7	1.62e-03	7	167	2	PF03828
Domain	PAP_assoc	TUT4 TUT7	1.62e-03	7	167	2	IPR002058
Domain	G_CP	GNL3L GNL3	1.62e-03	7	167	2	PS51721
Domain	Laminin_G	CNTNAP3B CNTNAP3 CNTNAP4 USH2A	1.80e-03	58	167	4	IPR001791
Domain	FN3	DCC PTPRD CNTN5 USH2A IL23R LRIT1 SORL1	2.12e-03	199	167	7	PS50853
Domain	EGF_1	ATRN CNTNAP3B CNTNAP3 TENM3 MEGF9 TENM1 CNTNAP4 USH2A	2.13e-03	255	167	8	PS00022
Domain	Glyco_trans_14	GCNT3 GCNT2	2.15e-03	8	167	2	IPR003406
Domain	Branch	GCNT3 GCNT2	2.15e-03	8	167	2	PF02485
Domain	EGF_LAM_2	ATRN MEGF9 USH2A	2.39e-03	30	167	3	PS50027
Domain	EGF_LAM_1	ATRN MEGF9 USH2A	2.39e-03	30	167	3	PS01248
Domain	EGF_2	ATRN CNTNAP3B CNTNAP3 TENM3 MEGF9 TENM1 CNTNAP4 SORL1	2.69e-03	265	167	8	PS01186
Domain	MYTH4	PLEKHH2 MYO15A	2.75e-03	9	167	2	PS51016
Domain	MyTH4	PLEKHH2 MYO15A	2.75e-03	9	167	2	SM00139
Domain	MyTH4_dom	PLEKHH2 MYO15A	2.75e-03	9	167	2	IPR000857
Domain	MyTH4	PLEKHH2 MYO15A	2.75e-03	9	167	2	PF00784
Domain	FN3_dom	DCC PTPRD CNTN5 USH2A IL23R LRIT1 SORL1	2.79e-03	209	167	7	IPR003961
Domain	FIBRINOGEN_C_1	CNTNAP3B CNTNAP3 CNTNAP4	2.88e-03	32	167	3	PS00514
Domain	Fibrinogen_a/b/g_C_dom	CNTNAP3B CNTNAP3 CNTNAP4	2.88e-03	32	167	3	IPR002181
Domain	Plexin_repeat	ATRN SEMA5A SEMA3G	2.88e-03	32	167	3	IPR002165
Domain	FIBRINOGEN_C_2	CNTNAP3B CNTNAP3 CNTNAP4	2.88e-03	32	167	3	PS51406
Domain	PSI	ATRN SEMA5A SEMA3G	2.88e-03	32	167	3	PF01437
Domain	An_peroxidase	DUOX2 EPX	3.41e-03	10	167	2	PF03098
Domain	Haem_peroxidase_animal	DUOX2 EPX	3.41e-03	10	167	2	IPR019791
Domain	Haem_peroxidase	DUOX2 EPX	3.41e-03	10	167	2	IPR010255
Domain	PEROXIDASE_3	DUOX2 EPX	3.41e-03	10	167	2	PS50292
Domain	-	DUOX2 EPX	3.41e-03	10	167	2	1.10.640.10
Domain	ARM-type_fold	DCAF1 RIPOR2 DOCK11 NCDN AP4E1 UPF2 TTI1 PRKDC XPOT	3.51e-03	339	167	9	IPR016024
Domain	TPR_REGION	TTC39C TMTC2 TTC3 VPS13A TTC21B PRKDC	3.71e-03	165	167	6	PS50293
Domain	TPR	TTC39C TMTC2 TTC3 VPS13A TTC21B PRKDC	3.71e-03	165	167	6	PS50005
Domain	EGF_Lam	ATRN MEGF9 USH2A	3.72e-03	35	167	3	SM00180
Domain	Laminin_EGF	ATRN MEGF9 USH2A	3.72e-03	35	167	3	PF00053
Domain	NTP_transf_2	TUT4 TUT7	4.15e-03	11	167	2	PF01909
Domain	Polymerase_NTP_transf_dom	TUT4 TUT7	4.15e-03	11	167	2	IPR002934
Domain	Laminin_EGF	ATRN MEGF9 USH2A	4.71e-03	38	167	3	IPR002049
Domain	ABC_A	ABCA13 ABCA6	4.95e-03	12	167	2	IPR026082
Domain	DUF4599	SPATA31A6 SPATA31D1	4.95e-03	12	167	2	PF15371
Domain	DUF4599	SPATA31A6 SPATA31D1	4.95e-03	12	167	2	IPR027970
Domain	-	TENM3 TENM1 SORL1	5.07e-03	39	167	3	2.120.10.30
Domain	EGF_3	ATRN CNTNAP3B CNTNAP3 TENM3 TENM1 CNTNAP4 SORL1	5.28e-03	235	167	7	PS50026
Domain	NHL	TENM3 TENM1	5.81e-03	13	167	2	PS51125
Domain	Dynein_heavy_chain_D4_dom	DNAH7 DNAH8	6.74e-03	14	167	2	IPR024317
Domain	Dynein_HC_stalk	DNAH7 DNAH8	6.74e-03	14	167	2	IPR024743
Domain	Myotubularin-like_Pase_dom	MTMR10 MTMR6	6.74e-03	14	167	2	IPR010569
Domain	Dynein_heavy_dom-2	DNAH7 DNAH8	6.74e-03	14	167	2	IPR013602
Domain	DHC_N2	DNAH7 DNAH8	6.74e-03	14	167	2	PF08393
Domain	MT	DNAH7 DNAH8	6.74e-03	14	167	2	PF12777
Domain	AAA_8	DNAH7 DNAH8	6.74e-03	14	167	2	PF12780
Domain	PPASE_MYOTUBULARIN	MTMR10 MTMR6	6.74e-03	14	167	2	PS51339
Domain	Myotubularin_fam	MTMR10 MTMR6	6.74e-03	14	167	2	IPR030564
Domain	Myotub-related	MTMR10 MTMR6	6.74e-03	14	167	2	PF06602
Domain	CNH	CDC42BPB MAP4K2	6.74e-03	14	167	2	SM00036
Domain	PSI	ATRN SEMA5A SEMA3G	7.11e-03	44	167	3	IPR016201
Domain	-	GNL3L ABCA13 SLFN5 DNAH7 ZRANB3 DHX15 RAB36 ABCA6 ERCC6L2 NMRK1 TJP2 MYO15A DNAH8 GNL3	7.20e-03	746	167	14	3.40.50.300
Domain	DHC_fam	DNAH7 DNAH8	7.73e-03	15	167	2	IPR026983
Domain	Dynein_heavy	DNAH7 DNAH8	7.73e-03	15	167	2	PF03028
Domain	CNH	CDC42BPB MAP4K2	7.73e-03	15	167	2	PF00780
Domain	Dynein_heavy_dom	DNAH7 DNAH8	7.73e-03	15	167	2	IPR004273
Domain	CNH	CDC42BPB MAP4K2	7.73e-03	15	167	2	PS50219
Domain	CNH_dom	CDC42BPB MAP4K2	7.73e-03	15	167	2	IPR001180
Domain	FERM_M	FRMD6 PLEKHH2 MYO15A	8.04e-03	46	167	3	PF00373
Domain	6-blade_b-propeller_TolB-like	TENM3 TENM1 SORL1	8.04e-03	46	167	3	IPR011042
Domain	PSI	ATRN SEMA5A SEMA3G	8.04e-03	46	167	3	SM00423
Domain	Galactosyl_T	B3GALNT2 B3GALT5	8.78e-03	16	167	2	PF01762
Pubmed	Amyloidosis causes downregulation of SorLA, SorCS1 and SorCS3 expression in mice.	SORCS1 SORCS3 SORL1	1.23e-07	3	174	3	31095505
Pubmed	A programmed wave of uridylation-primed mRNA degradation is essential for meiotic progression and mammalian spermatogenesis.	TUT4 TUT7 UPF2	1.22e-06	5	174	3	30617251
Pubmed	A global genomic transcriptional code associated with CNS-expressed genes.	CARMIL1 ITGA2 GCNT2 TTC3 SORCS1 FANCC TENM3 SORCS3 FOXP1 USH2A	5.10e-06	318	174	10	16919269
Pubmed	Protein interactome mining defines melatonin MT1 receptors as integral component of presynaptic protein complexes of neurons.	RIPOR2 AP4E1 EEF1G MTMR6 PTPRD RNF2 TENM3 ANKRD12 PRKDC MPZL2	5.69e-06	322	174	10	26514267
Pubmed	Human immunodeficiency virus type 1 Vpr links proteasomal degradation and checkpoint activation.	DCAF1 UBR1 UBR3	1.01e-05	9	174	3	17855541
Pubmed	Zfhx3 is required for the differentiation of late born D1-type medium spiny neurons.	CNTNAP3B CNTNAP3 FRMD6 FOXP1	1.30e-05	29	174	4	31491374
Pubmed	SORCS1 and SORCS3 control energy balance and orexigenic peptide production.	SORCS1 SORCS3	2.49e-05	2	174	2	29440124
Pubmed	Different developmental arrest points in RAG-2 -/- and SCID thymocytes on two genetic backgrounds: developmental choices and cell death mechanisms before TCR gene rearrangement.	RAG2 PRKDC	2.49e-05	2	174	2	9126963
Pubmed	High expression of PRKDC promotes breast cancer cell growth via p38 MAPK signaling and is associated with poor survival.	MAPK14 PRKDC	2.49e-05	2	174	2	31513357
Pubmed	TUT4/7-mediated uridylation of a coronavirus subgenomic RNAs delays viral replication.	TUT4 TUT7	2.49e-05	2	174	2	37085578
Pubmed	Cardiac Nav 1.5 is modulated by ubiquitin protein ligase E3 component n-recognin UBR3 and 6.	FBXO11 UBR3	2.49e-05	2	174	2	26059563
Pubmed	Caspr3-Deficient Mice Exhibit Low Motor Learning during the Early Phase of the Accelerated Rotarod Task.	CNTNAP3B CNTNAP3	2.49e-05	2	174	2	26807827
Pubmed	TUT7 controls the fate of precursor microRNAs by using three different uridylation mechanisms.	TUT4 TUT7	2.49e-05	2	174	2	25979828
Pubmed	Cardiovascular adaptations of pregnancy in T and B cell-deficient mice.	RAG2 PRKDC	2.49e-05	2	174	2	21613629
Pubmed	ATG5 promotes eosinopoiesis but inhibits eosinophil effector functions.	ATG5 EPX	2.49e-05	2	174	2	33598715
Pubmed	The RNA uridyltransferase Zcchc6 is expressed in macrophages and impacts innate immune responses.	TUT4 TUT7	2.49e-05	2	174	2	28665939
Pubmed	RNA uridyl transferases TUT4/7 differentially regulate miRNA variants depending on the cancer cell type.	TUT4 TUT7	2.49e-05	2	174	2	34949722
Pubmed	The critical role of ASD-related gene CNTNAP3 in regulating synaptic development and social behavior in mice.	CNTNAP3B CNTNAP3	2.49e-05	2	174	2	31150793
Pubmed	Dendritic cells require T cells for functional maturation in vivo.	RAG2 PRKDC	2.49e-05	2	174	2	10591187
Pubmed	Mucin biosynthesis: molecular cloning and expression of mouse mucus-type core 2 beta1,6 N-acetylglucosaminyltransferase.	GCNT3 GCNT2	2.49e-05	2	174	2	17591617
Pubmed	Diabetes-associated SorCS1 regulates Alzheimer's amyloid-beta metabolism: evidence for involvement of SorL1 and the retromer complex.	SORCS1 SORL1	2.49e-05	2	174	2	20881129
Pubmed	Memory CD4+ T cells are required for optimal NK cell effector functions against the opportunistic fungal pathogen Pneumocystis murina.	RAG2 PRKDC	2.49e-05	2	174	2	23203926
Pubmed	T cell receptor gamma and delta gene rearrangements in scid thymocytes. Similarity to those in normal thymocytes.	RAG2 PRKDC	2.49e-05	2	174	2	1661315
Pubmed	Isolation of expressed sequences encoded by the human Xq terminal portion using microclone probes generated by laser microdissection.	ATP6AP1 ATP11C	2.49e-05	2	174	2	8034313
Pubmed	Identification and characterization of SorCS, a third member of a novel receptor family.	SORCS1 SORCS3	2.49e-05	2	174	2	10600506
Pubmed	Foxp1 is an essential transcriptional regulator of B cell development.	RAG2 FOXP1	2.49e-05	2	174	2	16819554
Pubmed	Inhibition of autophagy through MAPK14-mediated phosphorylation of ATG5.	ATG5 MAPK14	2.49e-05	2	174	2	23235332
Pubmed	Uridylation by TUT4 and TUT7 marks mRNA for degradation.	TUT4 TUT7	2.49e-05	2	174	2	25480299
Pubmed	Terminal Uridylyltransferases TUT4/7 Regulate microRNA and mRNA Homeostasis.	TUT4 TUT7	2.49e-05	2	174	2	36497000
Pubmed	TAZ interacts with zonula occludens-1 and -2 proteins in a PDZ-1 dependent manner.	WWTR1 TJP2	7.44e-05	3	174	2	20850437
Pubmed	3' Uridylation Confers miRNAs with Non-canonical Target Repertoires.	TUT4 TUT7	7.44e-05	3	174	2	31178353
Pubmed	mRNA 3' uridylation and poly(A) tail length sculpt the mammalian maternal transcriptome.	TUT4 TUT7	7.44e-05	3	174	2	28792939
Pubmed	Alveolar macrophages in neonatal mice are inherently unresponsive to Pneumocystis murina infection.	RAG2 PRKDC	7.44e-05	3	174	2	22665378
Pubmed	Multigenerational autosomal dominant inheritance of 5p chromosomal deletions.	SEMA5A ICE1	7.44e-05	3	174	2	26601658
Pubmed	TENT2, TUT4, and TUT7 selectively regulate miRNA sequence and abundance.	TUT4 TUT7	7.44e-05	3	174	2	36071058
Pubmed	Microdeletion of 9q22.3: A patient with minimal deletion size associated with a severe phenotype.	FANCC ERCC6L2	7.44e-05	3	174	2	33960642
Pubmed	The three sorCS genes are differentially expressed and regulated by synaptic activity.	SORCS1 SORCS3	7.44e-05	3	174	2	15009648
Pubmed	Mono-uridylation of pre-microRNA as a key step in the biogenesis of group II let-7 microRNAs.	TUT4 TUT7	7.44e-05	3	174	2	23063654
Pubmed	Feasibility of Telomerase-Specific Adoptive T-cell Therapy for B-cell Chronic Lymphocytic Leukemia and Solid Malignancies.	RAG2 PRKDC	7.44e-05	3	174	2	27197263
Pubmed	Reversal of malignant ADAR1 splice isoform switching with Rebecsinib.	RAG2 PRKDC	7.44e-05	3	174	2	36803553
Pubmed	The SCID but not the RAG-2 gene product is required for S mu-S epsilon heavy chain class switching.	RAG2 PRKDC	7.44e-05	3	174	2	8885865
Pubmed	Resistance to skin tumorigenesis in DNAPK-deficient SCID mice is not due to immunodeficiency but results from hypersensitivity to TPA-induced apoptosis.	RAG2 PRKDC	7.44e-05	3	174	2	10545405
Pubmed	The RAG-1/2 endonuclease causes genomic instability and controls CNS complications of lymphoblastic leukemia in p53/Prkdc-deficient mice.	RAG2 PRKDC	7.44e-05	3	174	2	12559174
Pubmed	Uridylation by TUT4/7 Restricts Retrotransposition of Human LINE-1s.	TUT4 TUT7	7.44e-05	3	174	2	30122351
Pubmed	Differences between immunodeficient mice generated by classical gene targeting and CRISPR/Cas9-mediated gene knockout.	RAG2 PRKDC	7.44e-05	3	174	2	29594927
Pubmed	Distinct roles of stress-activated protein kinases in Fanconi anemia-type C-deficient hematopoiesis.	FANCC MAPK14	7.44e-05	3	174	2	19168785
Pubmed	Xenogeneic graft-versus-host-disease in NOD-scid IL-2Rγnull mice display a T-effector memory phenotype.	RAG2 PRKDC	7.44e-05	3	174	2	22937164
Pubmed	Molecular cloning and expression of a novel beta-1, 6-N-acetylglucosaminyltransferase that forms core 2, core 4, and I branches.	GCNT3 GCNT2	7.44e-05	3	174	2	9915862
Pubmed	TAZ stimulates exercise-induced muscle satellite cell activation via Pard3-p38 MAPK-TAZ signalling axis.	WWTR1 MAPK14	7.44e-05	3	174	2	37923703
Pubmed	Opposing consequences of IL-23 signaling mediated by innate and adaptive cells in chemically induced colitis in mice.	RAG2 IL23R	7.44e-05	3	174	2	22089030
Pubmed	Hidden Twins: SorCS Neuroreceptors Form Stable Dimers.	SORCS1 SORCS3	7.44e-05	3	174	2	28827148
Pubmed	V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors.	RAG2 PRKDC	7.44e-05	3	174	2	8769647
Pubmed	B cell acute lymphoblastic leukemia cells mediate RANK-RANKL-dependent bone destruction.	RAG2 PRKDC	7.44e-05	3	174	2	32938796
Pubmed	HIV-1 gp120-induced migration of dendritic cells is regulated by a novel kinase cascade involving Pyk2, p38 MAP kinase, and LSP1.	MAPK14 LSP1	7.44e-05	3	174	2	19700666
Pubmed	Spatiotemporal expression analysis of the growth factor receptor SorCS3.	SORCS1 SORCS3	7.44e-05	3	174	2	24715575
Pubmed	Cell adhesion molecule contactin-associated protein 3 is expressed in the mouse basal ganglia during early postnatal stages.	CNTNAP3B CNTNAP3 CNTNAP4	7.95e-05	17	174	3	26389685
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	TUT4 GNL3L GCNT3 TUT7 KAT2A SEMA3G DPP8 CDC42BPB DMXL1 MTMR6 MAPK14 PPA2 GNL3	8.54e-05	730	174	13	34857952
Pubmed	Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity.	UBR1 TTC3 RNF2 HACE1 UBR3	1.19e-04	95	174	5	29643511
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	ATRN ATP6AP1 DPY19L1 TUT7 B3GALNT2 CNTNAP3 TMTC2 ITGA2 CTSA MBOAT2 DMXL1 DHX15 TENM3 TTI1 ATP1B3 USP48 SORL1	1.19e-04	1201	174	17	35696571
Pubmed	SGK1 Governs the Reciprocal Development of Th17 and Regulatory T Cells.	RAG2 IL23R	1.48e-04	4	174	2	29346764
Pubmed	Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues.	TENM3 TENM1	1.48e-04	4	174	2	10225957
Pubmed	Dendritic cell-dependent in vivo generation of autoregulatory T cells by antidiabetogenic MHC class II.	RAG2 PRKDC	1.48e-04	4	174	2	23740949
Pubmed	Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo.	RAG2 PRKDC	1.48e-04	4	174	2	10202929
Pubmed	Anti-CD20 antibody therapy and susceptibility to Pneumocystis pneumonia.	RAG2 PRKDC	1.48e-04	4	174	2	25733518
Pubmed	Neither eosinophils nor neutrophils require ATG5-dependent autophagy for extracellular DNA trap formation.	ATG5 EPX	1.48e-04	4	174	2	28703297
Pubmed	Neuroprotective activity of pDING in response to HIV-1 Tat.	MAPK14 RNF2	1.48e-04	4	174	2	23955241
Pubmed	The genes for the human VPS10 domain-containing receptors are large and contain many small exons.	SORCS1 SORCS3	1.48e-04	4	174	2	11499680
Pubmed	Early thymocyte development is regulated by modulation of E2A protein activity.	RAG2 PRKDC	1.48e-04	4	174	2	11560990
Pubmed	Multi-domain utilization by TUT4 and TUT7 in control of let-7 biogenesis.	TUT4 TUT7	1.48e-04	4	174	2	28671666
Pubmed	Rag-dependent and Rag-independent mechanisms of Notch1 rearrangement in thymic lymphomas of Atm(-/-) and scid mice.	RAG2 PRKDC	1.48e-04	4	174	2	19000702
Pubmed	Homeostatic regulation of intestinal villous epithelia by B lymphocytes.	RAG2 PRKDC	1.48e-04	4	174	2	11884426
Pubmed	Creation of "humanized" mice to study human immunity.	RAG2 PRKDC	1.48e-04	4	174	2	18491294
Pubmed	Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice.	RAG2 PRKDC	1.48e-04	4	174	2	12438215
Pubmed	Roles for NBS1 in alternative nonhomologous end-joining of V(D)J recombination intermediates.	RAG2 PRKDC	1.48e-04	4	174	2	19362533
Pubmed	YAP/TAZ drives cell proliferation and tumour growth via a polyamine-eIF5A hypusination-LSD1 axis.	SAV1 WWTR1	1.48e-04	4	174	2	35177822
Pubmed	The Hippo Pathway Effector TAZ Regulates Ferroptosis in Renal Cell Carcinoma.	WWTR1 PRKDC	1.48e-04	4	174	2	31484063
Pubmed	GFAP Mutations in Astrocytes Impair Oligodendrocyte Progenitor Proliferation and Myelination in an hiPSC Model of Alexander Disease.	RAG2 PRKDC	1.48e-04	4	174	2	30075130
Pubmed	MuLV-related endogenous retroviral elements and Flt3 participate in aberrant end-joining events that promote B-cell leukemogenesis.	RAG2 PRKDC	1.48e-04	4	174	2	24888589
Pubmed	GNL3L depletion destabilizes MDM2 and induces p53-dependent G2/M arrest.	GNL3L GNL3	1.48e-04	4	174	2	21132010
Pubmed	Vaccine activation of the nutrient sensor GCN2 in dendritic cells enhances antigen presentation.	ATG5 RAG2	1.48e-04	4	174	2	24310610
Pubmed	Lin28-mediated control of let-7 microRNA expression by alternative TUTases Zcchc11 (TUT4) and Zcchc6 (TUT7).	TUT4 TUT7	1.48e-04	4	174	2	22898984
Pubmed	IL-23R+ innate lymphoid cells induce colitis via interleukin-22-dependent mechanism.	RAG2 IL23R	1.48e-04	4	174	2	23715173
Pubmed	All four members of the Ten-m/Odz family of transmembrane proteins form dimers.	TENM3 TENM1	1.48e-04	4	174	2	12000766
Pubmed	Molecular genetics of successful smoking cessation: convergent genome-wide association study results.	SEMA5A TMTC2 SORCS1 PTPRD USH2A	1.59e-04	101	174	5	18519826
Pubmed	Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	ICE1 DNAH7 PIKFYVE VPS13A DIP2C	1.67e-04	102	174	5	10231032
Pubmed	Expression of the immunoglobulin superfamily cell adhesion molecules in the developing spinal cord and dorsal root ganglion.	DCC PTPRD CNTN5 FOXP1 MPZL2 LRIT1	1.73e-04	162	174	6	25826454
Pubmed	FoxP1 orchestration of ASD-relevant signaling pathways in the striatum.	CNTNAP3B CNTNAP3 FOXP1	1.77e-04	22	174	3	26494785
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	KBTBD3 ATRN TUT4 GNL3L CARMIL1 B3GALNT2 SLITRK3 TECTA TTC3 BABAM2 CDC42BPB NCDN PNPLA6 TTC21B SPACA6 DIP2C FOXP1 ANKRD12 GNL3	1.80e-04	1489	174	19	28611215
Pubmed	Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.	RAG2 TUT4 CACUL1 SLITRK3 TTC3 LY6G5B AP4E1 GOLPH3L SYCP1 TBC1D12 ATP11C PLD5	1.89e-04	686	174	12	29987050
Pubmed	Telencephalic embryonic subtractive sequences: a unique collection of neurodevelopmental genes.	ZNF562 DPY19L1 DCC DHX15 PTPRD RNF2	1.91e-04	165	174	6	16107646
Pubmed	DNA cloning using in vitro site-specific recombination.	ATP6AP1 TUT7 TMTC2 EPX MTMR10 ZRANB3 RAB36 TMEM130 MTMR6 ZMYND10 PPA2 TJP2 PLEKHH2	1.95e-04	794	174	13	11076863
Pubmed	Spatial, a gene expressed in thymic stromal cells, depends on three-dimensional thymus organization for its expression.	RAG2 PRKDC	2.46e-04	5	174	2	11196687
Pubmed	Nucleostemin prevents telomere damage by promoting PML-IV recruitment to SUMOylated TRF1.	GNL3L GNL3	2.46e-04	5	174	2	22641345
Pubmed	Regulation of autophagy by the p300 acetyltransferase.	ATG5 KAT2A	2.46e-04	5	174	2	19124466
Pubmed	Endoplasmic reticulum stress in the intestinal epithelium initiates purine metabolite synthesis and promotes Th17 cell differentiation in the gut.	RAG2 DUOX2	2.46e-04	5	174	2	36917985
Pubmed	ATM prevents the persistence and propagation of chromosome breaks in lymphocytes.	RAG2 PRKDC	2.46e-04	5	174	2	17599403
Pubmed	B cell production of tumor necrosis factor in response to Pneumocystis murina infection in mice.	RAG2 PRKDC	2.46e-04	5	174	2	24002064
Pubmed	DNA double-strand breaks relieve USF-mediated repression of Dβ2 germline transcription in developing thymocytes.	RAG2 PRKDC	2.46e-04	5	174	2	22287717
Pubmed	Caspr3 and caspr4, two novel members of the caspr family are expressed in the nervous system and interact with PDZ domains.	CNTNAP3 CNTNAP4	2.46e-04	5	174	2	12093160
Pubmed	Transcription factors E2A, FOXO1 and FOXP1 regulate recombination activating gene expression in cancer cells.	RAG2 FOXP1	2.46e-04	5	174	2	21655267
Cytoband	10q23-q25	SORCS1 SORCS3	8.43e-05	4	173	2	10q23-q25
GeneFamily	Ubiquitin protein ligase E3 component n-recognins	UBR1 FBXO11 UBR3	6.36e-06	7	104	3	785
GeneFamily	Fibronectin type III domain containing	DCC PTPRD CNTN5 USH2A LRIT1 SORL1	3.25e-04	160	104	6	555
GeneFamily	Non-canonical poly(A) polymerases	TUT4 TUT7	6.75e-04	7	104	2	1318
GeneFamily	Glucosaminyl (N-acetyl) transferases/xylosyltransferases	GCNT3 GCNT2	8.97e-04	8	104	2	441
GeneFamily	ATP binding cassette subfamily A	ABCA13 ABCA6	2.85e-03	14	104	2	805
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	FRMD6 PLEKHH2 MYO15A	2.98e-03	50	104	3	1293
GeneFamily	Myotubularins\|Phosphoinositide phosphatases	MTMR10 MTMR6	3.28e-03	15	104	2	903
GeneFamily	Dyneins, axonemal	DNAH7 DNAH8	4.21e-03	17	104	2	536
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	TTC39C TMTC2 TTC3 TTC21B	4.38e-03	115	104	4	769
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B DCHS2 ABO DPY19L1 CNTNAP3 DGKG SEMA5A TECTA TENM1 SORCS3	2.01e-09	177	173	10	4c069f0d044a96118090b85ca592a21d6b5d9399
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B ABO DPY19L1 CNTNAP3 DGKG SEMA5A TECTA TENM3 TENM1 CNTNAP4	2.36e-09	180	173	10	e8841ef1239f9ee73ac4f4e11faca0742694f368
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B DCHS2 ABO DPY19L1 CNTNAP3 DGKG SEMA5A TECTA TENM1 SORCS3	2.49e-09	181	173	10	08f44323bf71b6004a921bbc969c954c75feeb66
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANKK1 DCC TECTA SORCS1 SYCP1 CNTNAP4 PLD5 PLEKHH2 USH2A	1.37e-08	160	173	9	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANKK1 DCC TECTA SORCS1 SYCP1 CNTNAP4 PLD5 PLEKHH2 USH2A	1.37e-08	160	173	9	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B DCHS2 ABO DPY19L1 CNTNAP3 DGKG SEMA5A TECTA TENM1	3.12e-08	176	173	9	72a2a01618ce836bc843395d5095e9090759b4a6
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B ABO CNTNAP3 DGKG SEMA5A TECTA TENM3 TENM1 CNTNAP4	4.17e-08	182	173	9	72e65a23cd36085bc880087d3cae92395de918a1
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B ABO CNTNAP3 DGKG SEMA5A TECTA TENM3 TENM1 CNTNAP4	4.17e-08	182	173	9	05c167158815bf25d509df59ab386e1990712765
ToppCell	Anterior_Cingulate_gyrus_(CgG)\|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B DCHS2 RIPOR2 CNTNAP3 SEMA5A MBOAT2 EFNB3 TENM3 TENM1	5.02e-08	186	173	9	32af3f211f9ad5d5c6b86b83325cfbf2f8466b56
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LRAT DCHS2 ABO DPY19L1 CNTNAP3 DGKG SEMA5A TENM1	3.20e-07	168	173	8	7abaddbcc55e44653d54aa15464266aa6bd5c9d2
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LRAT DCHS2 ABO DPY19L1 DGKG SEMA5A TENM1 SORCS3	3.50e-07	170	173	8	417b77c12a7982b1ce4b4bc57f30335d261220f5
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B DCHS2 ABO DPY19L1 CNTNAP3 DGKG SEMA5A TENM1	4.00e-07	173	173	8	95c723b09254ae7131fe5ba0841472502e83269b
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 ABO CNTNAP3 DGKG SEMA5A TECTA TENM1 SORCS3	4.18e-07	174	173	8	99eb5e1aee136c7039e23b68a43a0fa3d775859f
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B DCHS2 ABO DPY19L1 CNTNAP3 DGKG SEMA5A TENM1	4.97e-07	178	173	8	431e7557b8e8764e16e9e48368ce6bfa3c61561a
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CNTNAP3B DPY19L1 SEMA5A ITGA2 EFNB3 TENM3 SORCS3 PLD5	4.97e-07	178	173	8	a0ab20c588e7d43d0320d4779d9ab95c1c86e297
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B DCHS2 ABO CNTNAP3 DGKG SEMA5A SORCS1 TENM1	5.18e-07	179	173	8	7954c0026754ab869b88ab7feb13c2f27d6e272d
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B DCHS2 ABO DPY19L1 CNTNAP3 DGKG SEMA5A TENM1	5.41e-07	180	173	8	b514c55e52b46e8a1a2f09ed2c59a7683367a505
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 DCC SORCS1 PTPRD TENM1 CNTNAP4 MYO15A USH2A	6.39e-07	184	173	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 DCC SORCS1 PTPRD TENM1 CNTNAP4 MYO15A USH2A	6.39e-07	184	173	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 DCC SORCS1 PTPRD TENM1 CNTNAP4 MYO15A USH2A	6.39e-07	184	173	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	moderate-Epithelial-FOXN4+\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DPY19L1 ABCA13 CNTNAP3 SEMA5A DNAH7 RAB36 LRRIQ1 ZMYND10	9.52e-07	194	173	8	5dffa578149104dda33774361e9e77b227b5f1ce
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SEMA5A DCC PTPRD TENM3 ABCA6 KIAA1755 SORCS3 PLEKHH2	9.52e-07	194	173	8	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ABCA13 MPV17L DUOX2 DNAH7 ADGB RAB36 LRRIQ1 ZMYND10	9.89e-07	195	173	8	79dc031258579ea328181dda33710dd897f1064a
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SEMA5A PTPRD TENM3 FRMD6 ABCA6 KIAA1755 SORCS3 PLEKHH2	1.15e-06	199	173	8	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	COVID-19-kidney-Technical/muscle_(PCT)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DCC SORCS1 PTPRD SPATA16 CNTN5 CNTNAP4 SORCS3	1.23e-06	139	173	7	a1945b07f177cde40e7eea03a19236ce76165857
ToppCell	343B-Epithelial_cells-Epithelial-E_(AT2)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	DCAF1 DPY19L1 GCNT2 DMXL1 TMEM25 MEGF9 GSTCD	1.63e-06	145	173	7	80684ec249fa445c1b35f94608a4a6824d53f2d9
ToppCell	343B-Epithelial_cells-Epithelial-E_(AT2)\|343B / Donor, Lineage, Cell class and subclass (all cells)	DCAF1 DPY19L1 GCNT2 DMXL1 TMEM25 MEGF9 GSTCD	1.63e-06	145	173	7	cb534333fba44b241b14fb0d7b74e843f4e7f9f8
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DCC SPATA16 CNTN5 CNTNAP4 SORCS3 USH2A DNAH8	2.04e-06	150	173	7	0205318a870e091add66ee4305747dda9f51510d
ToppCell	RA-01._Fibroblast_I\|RA / Chamber and Cluster_Paper	DUOX2 TMTC2 SORCS1 ABCA6 C10orf126 LSP1 ATP1B3	4.49e-06	169	173	7	6373562ab3b1765060212a6a53d6543e7e942e80
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B DCHS2 ABO DPY19L1 CNTNAP3 DGKG SEMA5A	5.44e-06	174	173	7	321c6cae614d28feeee266eeb3499f2053ab79e0
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 CNTNAP3 DGKG TMEM244 TENM3 FRMD6 PLEKHH2	5.86e-06	176	173	7	0710689e66deba179b0a8038cdd56b4834984f12
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B DCHS2 ABO CNTNAP3 DGKG SEMA5A TENM1	6.09e-06	177	173	7	bde307e67ad8e48a5ff4c0827015f4688f6b3e46
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B DOCK11 CNTNAP3 MTMR6 TENM3 TENM1 PLD5	6.55e-06	179	173	7	d1365d48d1b017a7917f4f63a82ac4720c3d87df
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B DCHS2 ABO CNTNAP3 DGKG SEMA5A TENM1	6.55e-06	179	173	7	f65889bf1e41396979cce44a5e63f49dea2bbd9b
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RIPOR2 GLT1D1 DOCK11 ABCA13 SEMA5A DCC PTPRD	6.55e-06	179	173	7	58ae5a97fe2a14e1c6fdeb886397eb06fdaf0428
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RIPOR2 DOCK11 ABCA13 DNAH7 MTMR10 LRRIQ1 PLEKHH2	7.05e-06	181	173	7	6a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RIPOR2 DOCK11 ABCA13 SEMA5A FANCC PTPRD PLEKHH2	7.30e-06	182	173	7	5e1b316599436740f1b30875f0ebd33c3edfb2b6
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B DCHS2 ABO CNTNAP3 DGKG SEMA5A TENM1	7.57e-06	183	173	7	65f2a5895d166189a095cf7ea9dda171f0419b08
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B DOCK11 CNTNAP3 MTMR6 TENM3 TENM1 PLD5	7.57e-06	183	173	7	04d3cc76038b8192c915f1c08c3e26f2ad3b3779
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DPY19L2 ABCA13 DNAH7 ADGB RAB36 LRRIQ1 ZMYND10	7.84e-06	184	173	7	5daff849625f2f41d56615569c0ed59cd733b34c
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	UPF2 MEGF9 CNTN5 CNTNAP4 SORCS3 USH2A DNAH8	8.42e-06	186	173	7	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CNTNAP3B LRAT DOCK11 SEMA5A DCC PTPRD DIP2C	8.72e-06	187	173	7	9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B DOCK11 CNTNAP3 MTMR6 TENM3 TENM1 PLD5	9.02e-06	188	173	7	8de5a07301f9b5984680c873e5a92395b5ed3dd3
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CNTNAP3B LRAT SEMA5A DCC PTPRD SLC16A4 TENM3	9.34e-06	189	173	7	28b502611829e4a24caff2562545c7db97686099
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GCNT3 SEMA5A SORCS1 TMEM130 TENM3 KIAA1755 SORCS3	9.34e-06	189	173	7	319e42f6e2322208de78bc666fb2c074707eb4da
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DCC ITIH2 SORCS1 ABCA6 SPATA16 PLEKHH2	9.52e-06	125	173	6	b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GCNT3 MPV17L CARMIL1 DUOX2 B3GALT5 MBOAT2 TJP2	9.67e-06	190	173	7	6ea9fa08bd97bedcb21d3654467e7f8dd74c8fd0
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SEMA5A PTPRD TENM3 FRMD6 KIAA1755 SORCS3 PLEKHH2	9.67e-06	190	173	7	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SEMA5A DCC PTPRD TENM3 ABCA6 SORCS3 PLEKHH2	1.00e-05	191	173	7	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SEMA5A DCC PTPRD TENM3 ABCA6 SORCS3 PLEKHH2	1.03e-05	192	173	7	6f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SEMA5A DCC PTPRD TENM3 ABCA6 SORCS3 PLEKHH2	1.03e-05	192	173	7	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SEMA5A DCC PTPRD TENM3 ABCA6 SORCS3 PLEKHH2	1.07e-05	193	173	7	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SEMA5A DCC PTPRD TENM3 ABCA6 SORCS3 PLEKHH2	1.11e-05	194	173	7	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SEMA5A DCC PTPRD TENM3 ABCA6 SORCS3 PLEKHH2	1.11e-05	194	173	7	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	RAG2 DPY19L2 DNAH7 ADGB RAB36 LRRIQ1 ZMYND10	1.14e-05	195	173	7	e525b69145059b66417589601f7109af63730f3a
ToppCell	E12.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SEMA5A TMTC2 PTPRD TENM3 FOXP1 LSP1 ANKRD12	1.14e-05	195	173	7	febe746099964b9ea9e75f2efc72c962c01f0421
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TTC39C SORCS1 PTPRD CNTN5 FOXP1 PLEKHH2 SORL1	1.14e-05	195	173	7	787e95fb59c40bba784544b662fac37606ae1427
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TTC39C CARMIL1 SORCS1 PTPRD VPS13A FOXP1 SORL1	1.14e-05	195	173	7	2e1df01bf6e4e98e6cd9fb50926e34c5077b8666
ToppCell	distal-3-Epithelial-Proximal_Ciliated\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ANKK1 ABCA13 TCP11X2 DNAH7 RAB36 LRRIQ1 ZMYND10	1.22e-05	197	173	7	15b4d1203943ce90a7083178d4a4284d9b323071
ToppCell	Mild/Remission-B_naive-1\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	RIPOR2 TUT4 TUT7 ICE1 EEF1G PLEKHH2	2.05e-05	143	173	6	bd3f5fbd4e9e4dc414682db5607494f3ce988deb
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANKK1 ABCA13 TECTA TENM1 MYO15A USH2A	2.21e-05	145	173	6	96712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DCC SPATA16 CNTN5 CNTNAP4 USH2A DNAH8	2.49e-05	148	173	6	d6ac5972267254651dfbe16bb4e9a62228093cc7
ToppCell	LPS_only-Epithelial_airway-Ciliated_cells-Ciliated\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH7 ADGB RAB36 LRRIQ1 ZMYND10 USH2A	3.11e-05	154	173	6	9ca71d440c4f87781e6525b8141e7d8d470b6a8e
ToppCell	LPS_only-Epithelial_airway-Ciliated_cells\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH7 ADGB RAB36 LRRIQ1 ZMYND10 USH2A	3.11e-05	154	173	6	58072ce422d09f2de602580325eaac6c4ec6c136
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DUOX2 DNAH7 ADGB RAB36 LRRIQ1 ZMYND10	3.22e-05	155	173	6	5f1e2195a6b831e1b636f5cc3a282ca423721822
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DUOX2 DNAH7 ADGB RAB36 LRRIQ1 ZMYND10	3.22e-05	155	173	6	0944429459f642a1bcc56edc1ec28aaecde3e2dc
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ANKK1 CNTNAP3 TMEM130 EFNB3 CNTNAP4 PLD5	3.46e-05	157	173	6	741d79c10cb87fa7f14080c6fccb1553c3a20bad
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DGKG SLITRK3 SLFN5 DCC EFNB3 ATP11C	3.72e-05	159	173	6	5ca96db4281abb5f646150ccf36adc66ab201c78
ToppCell	Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MPV17L SEMA5A SLC22A17 FANCC GSTCD PLEKHH2	3.72e-05	159	173	6	7cda111bb98f1241989e49d490bdf51a712ea589
ToppCell	Influenza_Severe-Neutrophil\|Influenza_Severe / Disease group and Cell class	CNTNAP3B RIPOR2 CNTNAP3 MBOAT2 RAB36 SORL1	3.99e-05	161	173	6	98c95b1b85d5427415af2ca8fb14849e97f6e8b5
ToppCell	facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_PP_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPV17L TTC39C TMEM130 EFNB3 TENM1 TMPRSS7	4.13e-05	162	173	6	ca1014e32996f777bff021830ce9a7cf4acf58d5
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Gpc3_Slc18a3\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	DOCK11 SEMA5A B3GALT5 TECTA SORCS1 SORCS3	4.27e-05	163	173	6	ec9a20cfe0d69430f9c68cddd1ab0e4a3e4554b8
ToppCell	Ciliated_cells-A-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	ADGB RAB36 LRRIQ1 EFNB3 ZMYND10 CNTN5	4.89e-05	167	173	6	edb722ee9b6ccd00fb038f702be8664020932659
ToppCell	Influenza_Severe-Neutrophil\|World / Disease group and Cell class	CNTNAP3B RIPOR2 CNTNAP3 MBOAT2 MAPK14 SORL1	5.22e-05	169	173	6	6e8e2580e19c96bcf7fa6a6d8c183df65f428396
ToppCell	LV-16._Neuronal\|LV / Chamber and Cluster_Paper	TTC39C ITGA2 SORCS1 TENM3 ABCA6 SORCS3	5.22e-05	169	173	6	a8fc8ab0f0757e939e213efb61c03cfe390bf7d2
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_CMAHP\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SEMA5A TMTC2 DCC PTPRD CNTN5 FOXP1	5.40e-05	170	173	6	49fc45d8a5c3ad89d1649fa46d7a285891379392
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ABO DGKG SEMA5A OCA2 TECTA SPATA16	5.76e-05	172	173	6	1cfea985c5959b38beea351b892cd5e92e27f927
ToppCell	Mild-CD4+_T_Exhausted\|World / Disease group and Cell class	RIPOR2 SLFN5 TECTA BABAM2 EEF1G ERCC6L2	5.76e-05	172	173	6	efe68d9477aa873b1637ee689f298120303aa322
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CNTNAP3 CNTN5 TENM1 PLD5 PLEKHH2	5.95e-05	173	173	6	61907116a1460bc157ba73b5edd108db7dd5de4b
ToppCell	severe_influenza-Neutrophil\|World / disease group, cell group and cell class (v2)	CNTNAP3B RIPOR2 CNTNAP3 MBOAT2 MAPK14 SORL1	6.14e-05	174	173	6	f9f07436b7d3f190800cd85d229f007032f391e1
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LRAT DCHS2 ABO DGKG TENM1 SORCS3	6.14e-05	174	173	6	e4d65fe121a32ac4cdd6312e7b8f867f0852e991
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LRAT DCHS2 DPY19L1 DGKG OCA2 SORCS3	6.14e-05	174	173	6	7d4b860e05b5931f6f9d757a68f75ff35597a47a
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B ABO CNTNAP3 DGKG SEMA5A TENM1	6.34e-05	175	173	6	90e29945aa861082c94bb4f331161adc3a6ef899
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RIPOR2 DOCK11 ABCA13 DNAH7 LRRIQ1 PLEKHH2	6.34e-05	175	173	6	284fdc7a9d303636a637041846850d19d114861a
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RIPOR2 DPY19L2 CARMIL1 MBOAT2 MEGF9 FOXP1	6.54e-05	176	173	6	6c7edf1cb38644500bce6c5a1dd90bbe17415cdb
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B ABO CNTNAP3 DGKG SEMA5A TENM1	6.54e-05	176	173	6	e4b21fd6a5e0c5950f27c3e1868318e48330ae5e
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ABO DPY19L1 DGKG SEMA5A TECTA TENM1	6.75e-05	177	173	6	57033ee0d49a4a50fc25328a4a44d4de2b35f505
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 CNTNAP3 DGKG TMEM244 TENM3 FRMD6	6.75e-05	177	173	6	f30d757ee8db7e10d547498dab6560473c6ed7c0
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 CNTNAP3 DGKG TMEM244 FRMD6 PLEKHH2	6.96e-05	178	173	6	6f61490d79cd1727ed2d5cc673823dd4efdafac1
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L3-6_PVALB_MFI2_(Chandelier_2)\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CNTNAP3 CNTN5 TENM1 PLD5 PLEKHH2	6.96e-05	178	173	6	c982a73955c9c193bcab21d60d453afcc09cd586
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANKK1 ABCA13 DNAH7 ADGB LRRIQ1 ZMYND10	6.96e-05	178	173	6	3b12db04006db6e94fc45649a4b3a63b92f21a61
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCC DNAH7 LRRIQ1 PTPRD CNTN5 PLEKHH2	6.96e-05	178	173	6	0e1bedf991189d0ef9b40dac9281bdf4739333a1
ToppCell	Ciliated_cells-A-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	DNAH7 ADGB RAB36 LRRIQ1 EFNB3 ZMYND10	7.18e-05	179	173	6	0e6c22de2e3fb0ff23b3301863cf4011c5c59dff
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 CNTNAP3 DGKG TENM3 FRMD6 PLEKHH2	7.18e-05	179	173	6	1ac79c82c52fa95bb4e170ab20fec0f648db2134
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CNTNAP3 CNTN5 TENM1 PLD5 PLEKHH2	7.18e-05	179	173	6	3b0f8781232e1d42b6f8913bc989a14b3f978e79
ToppCell	390C-Lymphocytic-ILC-ILC-1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	MBOAT2 MTMR10 TRIM62 VPS13A TTC21B ZNF75D	7.18e-05	179	173	6	3edcd1356e49b1f5514c585861999e079ca5e579
ToppCell	390C-Lymphocytic-ILC-ILC-1\|390C / Donor, Lineage, Cell class and subclass (all cells)	MBOAT2 MTMR10 TRIM62 VPS13A TTC21B ZNF75D	7.18e-05	179	173	6	e7045e27f0eb88f552b31c04b56d78e5ccd7a36c
ToppCell	facs-Liver-Non-hepatocytes-3m-Lymphocytic-T_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GALT5 ITGA2 BCL9 ZRANB3 GTF2H3 DEF6	7.41e-05	180	173	6	87347af8f28cf7c486c19f3f98c0afb022c323b5
ToppCell	Ciliated_cells-A-Donor_07\|World / lung cells shred on cell class, cell subclass, sample id	DNAH7 ADGB RAB36 LRRIQ1 EFNB3 ZMYND10	7.41e-05	180	173	6	d9be152773fe9f2160edad9246fa03c03afeafd6
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DPY19L1 DCC SORCS1 CNTN5 CNTNAP4 FOXP1	7.64e-05	181	173	6	6e8c5460021d3999daec58e3d6661a6fa998fd16
Disease	Colorectal Carcinoma	ATG5 CACUL1 ZNF560 ABCA13 DCC NCDN PTPRD ABCA6 GUCY2C VPS13A TENM1 DIP2C ATP11C DNAH8 SORL1	7.64e-06	702	161	15	C0009402
Disease	autosomal recessive intellectual developmental disorder (implicated_via_orthology)	CNTNAP3B CNTNAP3 CNTNAP4	8.75e-06	8	161	3	DOID:0060308 (implicated_via_orthology)
Disease	cognitive function measurement, self reported educational attainment	CARMIL1 DPP8 DCC PKD1L3 FBXL4 PPA2 TTC21B CNTNAP4 SORCS3 FOXP1	2.72e-05	355	161	10	EFO_0004784, EFO_0008354
Disease	severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, Nk cell-positive (implicated_via_orthology)	RAG2 PRKDC	2.96e-05	2	161	2	DOID:0090013 (implicated_via_orthology)
Disease	renal sinus adipose tissue measurement	GLT1D1 TMEM244 TJP2	4.38e-05	13	161	3	EFO_0004864
Disease	Nonsyndromic Deafness	RIPOR2 TMTC2 TECTA TJP2 MYO15A	8.33e-05	81	161	5	C3711374
Disease	severe combined immunodeficiency (implicated_via_orthology)	RAG2 PRKDC	8.84e-05	3	161	2	DOID:627 (implicated_via_orthology)
Disease	hearing impairment	TECTA FANCC TJP2 MYO15A USH2A	2.05e-04	98	161	5	C1384666
Disease	metabolite measurement	ABO ICE1 DCC BABAM2 ZRANB3 SORCS1 UGT2B10 FOXP1 PLEKHH2 NDUFV1-DT SORL1	2.68e-04	560	161	11	EFO_0004725
Disease	coronary artery disease, factor VII measurement	TDRD15 ABO SEMA5A PNLDC1 MORF4L1	3.66e-04	111	161	5	EFO_0001645, EFO_0004619
Disease	unipolar depression, depressive symptom measurement	DCC CNTN5 SORCS3	3.78e-04	26	161	3	EFO_0003761, EFO_0007006
Disease	factor VIII measurement, coronary artery disease	TDRD15 ABO SEMA5A MORF4L1 MMAB	3.97e-04	113	161	5	EFO_0001645, EFO_0004630
Disease	non-alcoholic fatty liver disease severity measurement	SEMA5A PTPRD SORCS3	4.72e-04	28	161	3	EFO_0008421
Disease	von Willebrand factor measurement, coronary artery disease	TDRD15 ABO SEMA5A PNLDC1 MORF4L1	4.84e-04	118	161	5	EFO_0001645, EFO_0004629
Disease	hepatocyte growth factor receptor measurement	ABO ABCA6	6.10e-04	7	161	2	EFO_0008153
Disease	fructosamine measurement	CNTN5 MAP4K2	6.10e-04	7	161	2	EFO_0009303
Disease	juvenile idiopathic arthritis	ABCA13 CARMIL1 ERAP2 FOXP1	7.30e-04	74	161	4	EFO_0002609
Disease	sensorineural hearing loss (is_implicated_in)	ITGA2 TECTA MYO15A	7.71e-04	33	161	3	DOID:10003 (is_implicated_in)
Disease	clopidogrel metabolite measurement	SLFN5 RNF2 TBC1D12	7.71e-04	33	161	3	EFO_0007966
Disease	cerebellar ataxia (implicated_via_orthology)	PNPLA6 VPS13A	8.11e-04	8	161	2	DOID:0050753 (implicated_via_orthology)
Disease	blindness (implicated_via_orthology)	PNPLA6 MYO15A	8.11e-04	8	161	2	DOID:1432 (implicated_via_orthology)
Disease	semaphorin-3G measurement	ABO SEMA3G	8.11e-04	8	161	2	EFO_0802049
Disease	obsolete aging	GCNT3 GLT1D1 CARMIL1 OCA2 EPX CNTN5 DIP2C	8.87e-04	279	161	7	GO_0007568
Disease	nephronophthisis (implicated_via_orthology)	WWTR1 TTC21B	1.04e-03	9	161	2	DOID:12712 (implicated_via_orthology)
Disease	free cholesterol to total lipids in large VLDL percentage	TDRD15 ABO ABCA6	1.08e-03	37	161	3	EFO_0022281
Disease	facial morphology measurement	DCHS2 OCA2 DHX15 TMEM244 LRRIQ1 HACE1 SORCS3 FOXP1 USP48	1.09e-03	466	161	9	EFO_0007841
Disease	obsolete_red blood cell distribution width	ABO CARMIL1 TUT7 DUOX2 FREM3 EPG5 ABCA6 MORF4L1 CNTN5 VPS13A TBC1D12 UGT2B10 ATP11C ANKRD12 ATP1B3 MMAB GNL3	1.15e-03	1347	161	17	EFO_0005192
Disease	neurodegenerative disease (implicated_via_orthology)	UBR1 WWTR1 MTMR10 PNPLA6 UBR3	1.23e-03	145	161	5	DOID:1289 (implicated_via_orthology)
Disease	cholesterol in very small VLDL measurement	TDRD15 ABO ABCA6	1.36e-03	40	161	3	EFO_0022231
Disease	free cholesterol in medium LDL measurement	TDRD15 ABO ABCA6	1.36e-03	40	161	3	EFO_0022268
Disease	attention deficit hyperactivity disorder, autism spectrum disorder, intelligence	DPP8 DCC PKD1L3 PPA2 TTC21B SORCS3 FOXP1 ATP1B3	1.60e-03	398	161	8	EFO_0003756, EFO_0003888, EFO_0004337
Disease	pulse pressure measurement	TDRD15 ABO CARMIL1 EPX PKD1L3 SLC22A17 DHX15 PTPRD MORF4L1 TBC1D12 KIAA1755 UBR3 SORCS3 FOXP1 LSP1 ATP1B3 MAP4K2	1.63e-03	1392	161	17	EFO_0005763
Disease	concentration of large LDL particles measurement	TDRD15 ABO ABCA6	1.79e-03	44	161	3	EFO_0022160
Disease	cholesterol in medium VLDL measurement	TDRD15 ABO ABCA6	1.79e-03	44	161	3	EFO_0022225
Disease	cholesterol to total lipids in large VLDL percentage	TDRD15 ABO ABCA6	1.91e-03	45	161	3	EFO_0022236
Disease	free cholesterol in very small VLDL measurement	TDRD15 ABO ABCA6	2.17e-03	47	161	3	EFO_0022275
Disease	intercellular adhesion molecule 5 measurement	ABO ABCA6	2.22e-03	13	161	2	EFO_0008164
Disease	Alzheimer's disease biomarker measurement	WWTR1 CLDN24 SORL1	2.30e-03	48	161	3	EFO_0006514
Disease	malaria	ABO FREM3 DIP2C IL23R	2.40e-03	102	161	4	EFO_0001068
Disease	phospholipids in medium LDL measurement	TDRD15 ABO ABCA6	2.44e-03	49	161	3	EFO_0022183
Disease	cholesteryl esters to total lipids in small VLDL percentage	TDRD15 ABO ABCA6	2.44e-03	49	161	3	EFO_0022256
Disease	unipolar depression, anxiety	CLDN24 PTPRD	2.58e-03	14	161	2	EFO_0003761, EFO_0005230
Disease	free cholesterol in LDL measurement	TDRD15 ABO ABCA6	2.59e-03	50	161	3	EFO_0022266
Disease	free cholesterol in large LDL measurement	TDRD15 ABO ABCA6	2.74e-03	51	161	3	EFO_0022176
Disease	cholesterol to total lipids in small VLDL percentage	TDRD15 ABO ABCA6	2.74e-03	51	161	3	EFO_0022242
Disease	lymphocyte count	ATG5 CACNA1S RIPOR2 ABO GCNT2 EPX CHML RAB36 ZMYND10 GOLPH3L CNTN5 DEF6 PPA2 ERCC6L2 FOXP1 LSP1 ATP1B3	2.75e-03	1464	161	17	EFO_0004587
Disease	phospholipids in IDL measurement	TDRD15 ABO ABCA6	2.90e-03	52	161	3	EFO_0022164
Disease	total lipids in LDL measurement	TDRD15 ABO ABCA6	2.90e-03	52	161	3	EFO_0022308
Disease	bilirubin measurement	UBR1 DCHS2 ABO CARMIL1 EPX SPATA16 CNTN5 UGT2B10	3.05e-03	442	161	8	EFO_0004570
Disease	phospholipids in large LDL measurement	TDRD15 ABO ABCA6	3.06e-03	53	161	3	EFO_0022174
Disease	triglycerides to total lipids in very large VLDL percentage	TDRD15 ABO ABCA6	3.06e-03	53	161	3	EFO_0022340
Disease	free cholesterol in small LDL measurement	TDRD15 ABO ABCA6	3.06e-03	53	161	3	EFO_0022271
Disease	cholesteryl esters to total lipids in very large VLDL percentage	TDRD15 ABO ABCA6	3.06e-03	53	161	3	EFO_0022258
Disease	Ciliopathies	LRAT TTC21B USH2A DNAH8	3.15e-03	110	161	4	C4277690
Disease	non-alcoholic fatty liver disease, type 2 diabetes mellitus	ATRN ITIH2 TJP2 DNAH8	3.15e-03	110	161	4	EFO_0003095, MONDO_0005148
Disease	Hepatomegaly	ATG5 MBOAT2 MAPK14	3.23e-03	54	161	3	C0019209
Disease	cholesterol to total lipids in very large VLDL percentage	TDRD15 ABO ABCA6	3.23e-03	54	161	3	EFO_0022244
Disease	inflammatory bowel disease	GALC CARMIL1 KAT2A EPX ERAP2 FOXP1 LSP1 IL23R	3.36e-03	449	161	8	EFO_0003767
Disease	lipoprotein A measurement	DCAF1 TDRD15 PNLDC1 ABCA6	3.36e-03	112	161	4	EFO_0006925
Disease	alcohol consumption measurement	ANKK1 FBXO11 FBXW2 DCC PKD1L3 BABAM2 MBOAT2 DHX15 EFNB3 MEGF9 HACE1 FOXP1 MYO15A MMAB SORL1	3.39e-03	1242	161	15	EFO_0007878
Disease	Antithrombotic agent use measurement	TDRD15 ABO FANCC	3.40e-03	55	161	3	EFO_0009925
Disease	cholesteryl esters to total lipids in large VLDL percentage	TDRD15 ABO ABCA6	3.58e-03	56	161	3	EFO_0022250
Disease	factor XI measurement, coronary artery disease	TDRD15 ABO SEMA5A MORF4L1	3.69e-03	115	161	4	EFO_0001645, EFO_0004694
Disease	total lipids in large LDL	TDRD15 ABO ABCA6	3.76e-03	57	161	3	EFO_0022163
Disease	cholesterol in large LDL measurement	TDRD15 ABO ABCA6	3.76e-03	57	161	3	EFO_0021901
Disease	free cholesterol to total lipids in medium VLDL percentage	TDRD15 ABO ABCA6	3.76e-03	57	161	3	EFO_0022284
Disease	cholesterol to total lipids in chylomicrons and extremely large VLDL percentage	TDRD15 ABO	3.81e-03	17	161	2	EFO_0022232
Disease	Ischemic stroke, venous thromboembolism, stroke, Abnormal thrombosis, deep vein thrombosis, pulmonary embolism	LRAT ABO	3.81e-03	17	161	2	EFO_0000712, EFO_0003827, EFO_0003907, EFO_0004286, HP_0001977, HP_0002140
Disease	alkaline phosphatase measurement	TDRD15 RIPOR2 CACUL1 ABO CARMIL1 MPDU1 PKD1L3 BABAM2 RNF2 ABCA6 PLEKHH2 USP48 MAP4K2	3.87e-03	1015	161	13	EFO_0004533
Disease	macula measurement	DCHS2 GCNT3 OCA2 TJP2 SORL1	3.87e-03	189	161	5	EFO_0008375
Disease	triglycerides to total lipids in small VLDL percentage	TDRD15 ABO ABCA6	3.95e-03	58	161	3	EFO_0022338
Disease	cholesterol in IDL measurement	TDRD15 ABO ABCA6	3.95e-03	58	161	3	EFO_0021899
Disease	phospholipids in LDL measurement	TDRD15 ABO ABCA6	3.95e-03	58	161	3	EFO_0022294
Disease	HbA1c measurement	RIPOR2 ABO CARMIL1 MPDU1 FREM3 CNTN5 VPS13A PLEKHH2 MYO15A MAP4K2	4.07e-03	675	161	10	EFO_0004541
Disease	phospholipids in small LDL measurement	TDRD15 ABO ABCA6	4.14e-03	59	161	3	EFO_0022297
Disease	free cholesterol to total lipids in very large VLDL percentage	TDRD15 ABO ABCA6	4.14e-03	59	161	3	EFO_0022289
Disease	ferritin measurement	DUOX2 PTPRD TENM3 GNL3	4.17e-03	119	161	4	EFO_0004459
Disease	Colorectal Neoplasms	CACUL1 ABCA13 DCC PTPRD ABCA6 GUCY2C	4.25e-03	277	161	6	C0009404
Disease	Child Behaviour Checklist assessment	TENM3 SPATA16	4.27e-03	18	161	2	EFO_0005661
Disease	low density lipoprotein cholesterol measurement, phospholipid measurement	TDRD15 ABO ABCA6 DMWD	4.30e-03	120	161	4	EFO_0004611, EFO_0004639
Disease	total lipids in IDL	TDRD15 ABO ABCA6	4.34e-03	60	161	3	EFO_0022161
Disease	pain	DCC PKD1L3 SPATA16 SORCS3 MPZL2	4.51e-03	196	161	5	EFO_0003843
Disease	free cholesterol in IDL measurement	TDRD15 ABO ABCA6	4.55e-03	61	161	3	EFO_0022181
Disease	mean reticulocyte volume	RIPOR2 ABO KAT2A DPP8 SLC16A4 CNTN5 PPA2 VPS13A TBC1D12 FOXP1 MMAB	4.55e-03	799	161	11	EFO_0010701
Disease	smoking status measurement	FBXO11 DCC CDC42BPB PTPRD SPATA16 CNTN5 HACE1 CNTNAP4 SORCS3 FOXP1 PLD5 USH2A DNAH8 SORL1	4.64e-03	1160	161	14	EFO_0006527
Disease	chronic obstructive pulmonary disease	DCHS2 DGKG BCL9 FREM3 CNTN5 TRIM62 GSTCD ERCC6L2 FOXP1 DMWD	4.65e-03	688	161	10	EFO_0000341
Disease	pursuit maintenance gain measurement	CARMIL1 EPX EPG5 PTPRD	4.69e-03	123	161	4	EFO_0008433
Disease	wellbeing measurement	ANKK1 CARMIL1 DCC BABAM2 PTPRD CNTN5 PPA2 SORCS3 FOXP1 MMAB	4.84e-03	692	161	10	EFO_0007869
Disease	coronary artery disease, plasminogen activator inhibitor 1 measurement	TDRD15 ABO MORF4L1	4.98e-03	63	161	3	EFO_0001645, EFO_0004792
Disease	triglycerides to total lipids in medium VLDL percentage	TDRD15 ABO ABCA6	4.98e-03	63	161	3	EFO_0022335
Disease	cholesterol to total lipids in medium VLDL percentage	TDRD15 ABO ABCA6	4.98e-03	63	161	3	EFO_0022239
Disease	colorectal health	ATG5 SEMA5A BABAM2 HACE1 SORCS3	5.02e-03	201	161	5	EFO_0008460
Disease	diet measurement	TDRD15 ABO DPY19L1 CARMIL1 DGKG SLC22A17 CNTN5 PPA2 UBR3 SORCS3 FOXP1 PRKDC SORL1	5.08e-03	1049	161	13	EFO_0008111
Disease	cholesteryl esters to total lipids in medium VLDL percentage	TDRD15 ABO ABCA6	5.21e-03	64	161	3	EFO_0022253
Disease	exercise test	PTPRD CNTN5	5.27e-03	20	161	2	EFO_0004328
Disease	Severe Combined Immunodeficiency	RAG2 PRKDC	5.27e-03	20	161	2	C0085110
Disease	cognitive function measurement	ATG5 SZT2 DPP8 DCC PKD1L3 FBXL4 DHX15 PTPRD CNTN5 PPA2 TTC21B CNTNAP4 SORCS3 FOXP1 ATP1B3 USH2A	5.34e-03	1434	161	16	EFO_0008354

Protein segments in the cluster

Peptide	Gene	Start	Entry
DWIFTLYSKSLPLDL	TBC1D12	666	O60347
FEKSWLLLADIYIQS	TTC21B	1196	Q7Z4L5
LLILSKWLEQVYPSS	EPG5	2396	Q9HCE0
EYLQLRSKSWPVFLQ	ADCK1	66	Q86TW2
ITTYLPHWKNLNLDL	CLDN24	26	A6NM45
TPLVSNKYQWLQIDL	CNTNAP3	71	Q9BZ76
TKVLSPEYLWDQQLL	ABO	316	P16442
LYNSWPLTESQLTFV	ADGB	1261	Q8N7X0
IWELLTQKKPYSGFN	ANKK1	216	Q8NFD2
VFYEQLPSSLEWILN	ABCA6	346	Q8N139
SPLVSNKYQWLQIDL	CNTNAP4	71	Q9C0A0
ILFEINPKLLELWAY	ABCA13	826	Q86UQ4
FIKPRTLLDYWQALE	B3GALT5	286	Q9Y2C3
SKEWQPAVQILLYSL	CCKAR	36	P32238
LEWQLKLQELDPATY	ANKRD12	2021	Q6UB98
LQWLSEHLSYPDNFL	ATG5	251	Q9H1Y0
PEWVLYNEFVLTTKN	DHX15	731	O43143
VTYLKWLPESESLFL	DMWD	216	Q09019
YLQLWSNTNLEKPTE	DMXL1	131	Q9Y485
PLWASFLESLKKNDY	ECD	331	O95905
LAEKYAPDNAWFIQT	AP4E1	436	Q9UPM8
YWPKLDGAIDQLLTQ	CACUL1	136	Q86Y37
LDVTFYWTLKGQPID	CNTN5	601	O94779
EELTKPRLLWALYFN	CHML	541	P26374
DINTWVPFYSTELNK	RAG2	426	P55895
SILFSLYPDQGKLWQ	OCA2	191	Q04671
PYSLQIWDTAGQEKF	RAB36	171	O95755
LVNFWKTNDLPFKTY	GUCY2C	171	P25092
FLLCLNYWKLETPAQ	KAT2A	261	Q92830
EQWPKYTLTLLAQDQ	PCDH12	421	Q9NPG4
LLDVESYNPLSKEWI	KBTBD3	421	Q8NAB2
SLLLLQWYEPLQKFL	MAP4K2	621	Q12851
WDLITRQKQLFYLPA	MORF4L1	211	Q9UBU8
DKQIEDLWLPYFNVT	PNPLA6	1076	Q8IY17
AQLYWEPAEVFLKLS	DCAF1	581	Q9Y4B6
ILFYTLDKNIPIDDW	DCC	981	P43146
APSLLCKYFLQQWEL	NCDN	486	Q9UBB6
EPSQLKLFYDVITWI	MBOAT2	406	Q6ZWT7
DPDFTRKLWAYLTIN	ITIH2	576	P19823
SLWPFLLEDQKKYLN	MTMR6	456	Q9Y217
FLDATWQLLEQYPAA	MTMR10	466	Q9NXD2
VLWDQPLKFENELYV	MYO15A	3296	Q9UKN7
YPILFTQEWLEAINS	KIAA1755	141	Q5JYT7
PTFYRQELNKTIWEV	MAPK14	6	Q16539
WLVNSPSLFANKFEL	GCNT2	356	Q8N0V5
QSFWTREEYSNLKLP	ATRN	326	O75882
IAVYEWLPSFLQKTL	DUOX2	296	Q9NRD8
KFLNLYGTPDNIDIW	EPX	601	P11678
FLWSLQQFPKDTINE	DNAH8	3226	Q96JB1
SPEKQLTLNEIYNWF	FOXP1	481	Q9H334
ASIDPEYAKNLQWIL	HACE1	681	Q8IYU2
SNLPQEELIEWIKYS	DPY19L1	531	Q2PZI1
YQNRKLNAPFWTIEL	MEGF9	541	Q9H1U4
EKLLGFTPYSLLWNN	LRAT	146	O95237
PERYDASILLWKLQF	MPZL2	101	O60487
YVAEFLEWAKPFTQL	CDC42BPB	51	Q9Y5S2
NNLPQEELLQWIKYS	DPY19L2	616	Q6NUT2
ESNSIYPWDAVKNFL	ITGA2	181	P17301
YLTADSPNILEEWIK	PLEKHH2	776	Q8IVE3
EAFSSYWLPLLQNIT	LRRIQ1	1051	Q96JM4
EQLWLPYNALSELNA	LRIT1	86	Q9P2V4
SEYFPIWLQLKVTDQ	DCHS2	2101	Q6V1P9
WSEQDFQYLRQKLSP	SMPD2	51	O60906
SWNLIANVLYLESPA	CTSA	116	P10619
LVWSALPFITYLENK	POP5	76	Q969H6
WVSLTPEEFDQLQKY	DGKG	6	P49619
FAEQVYWSPLLNKEF	PIKFYVE	1081	Q9Y2I7
NLDEEKQLLYDFPWT	FRMD6	261	Q96NE9
KQLLYDFPWTNVGKL	FRMD6	266	Q96NE9
QLVSFTYIWIILKPN	GABRR3	6	A8MPY1
KPSIWISSQIYDQNF	ICE1	1516	Q9Y2F5
YWQSLPSAIRVKQEF	C6orf52	21	Q5T4I8
DTLLTYWNKVSPQEL	DOCK11	1296	Q5JSL3
TLKWDIIFNAQYPEL	BABAM2	66	Q9NXR7
QVKDPLYLVDAFSAW	GLT1D1	176	Q96MS3
STFEGWPQLLYKAID	CACNA1S	1011	Q13698
FSELANDPILWKRLY	FBXO11	186	Q86XK2
IHLNLQPYWAKLDDT	FBXL4	321	Q9UKA2
NVPAKLLNFYRWTVE	B3GALNT2	331	Q8NCR0
TPEQIAWLKLQQEFY	BCL9	466	O00512
SWKPLLDLFQATLDY	DPP8	131	Q6V1X1
LKVQATWLYLEPIFS	DNAH7	981	Q8WXX0
WNPFILAYDESQKIL	FANCC	76	Q00597
EDLLQSSVPWKYFLN	GCNT3	211	O95395
NKTTARLWYKNFLEP	IL23R	81	Q5VWK5
LLTGETWNPFKLQYQ	GOLPH3L	141	Q9H4A5
ETNPALWLLAVSQYK	DIP2C	1211	Q9Y2E4
LWCLFNFLSEDKYPL	DEF6	121	Q9H4E7
LPLSDSQIQWFYQAL	LY6G5B	126	Q8NDX9
DLPISKIDQWLEQYT	LSP1	221	P33241
LLQYFKPVIDRQSWS	ERAP2	726	Q6P179
DLVPKENLESWLNYL	GNL3	181	Q9BVP2
DLIPIIAALEYNQWF	CARMIL1	206	Q5VZK9
CTLLWLYKQVLEPSF	EEF1G	166	P26641
FLIVAPLSVLYNWKD	ERCC6L2	211	Q5T890
FYLLKWLDPQTLLTC	FBXW2	66	Q9UKT8
SFSEIPELQVWYTKL	GALC	416	P54803
LRFTIKFQEYSPNLW	EFNB3	111	Q15768
IVNFQLPKEEITYSW	SPACA6	171	W5XKT8
SEKLVEFPLLASWYQ	GSTCD	306	Q8NEC7
QPLSKTWELSLYELQ	RNF2	11	Q99496
TPLVSNKYQWLQIDL	CNTNAP3B	71	Q96NU0
LELEQWIDKYTSQLP	MMAB	151	Q96EY8
KTSVLLSWEIPENYN	PTPRD	1031	P23468
QRYADFAPSLLQVWK	UPF2	231	Q9HAU5
LLFNYKPLDTIWNRS	NMRK1	101	Q9NWW6
DDQNLWYTLLTLPTD	FREM3	736	P0C091
NWPATSLSIFYLLKI	TAS2R45	96	P59539
VLVLNWYATELNPAF	TAS2R46	61	P59540
EPWLKELSLAFLQQY	SZT2	2906	Q5T011
EWISFTTQKELPQYR	USH2A	4921	O75445
ALAFEPLSQLLYWVD	SORL1	836	Q92673
LLSFWKETDPLTFNF	PLD5	381	Q8N7P1
LLDKQPSLLDYTTKW	TCP11X1	231	B4DZS4
LLDKQPSLLDYTTKW	TCP11X2	136	Q5H9J9
LKDWDYNGLPVLTTN	SLC22A17	71	Q8WUG5
FYCQLIKWTPELENL	TDRD15	256	B5MCY1
PRLLQESFWKNYSQL	SPATA31A6	401	Q5VVP1
YIQSLLFHPKQEDWV	SORCS3	296	Q9UPU3
WLDYLRNELPTVAFK	GNL3L	186	Q9NVN8
QQISLFDLPSEWYLK	PNLDC1	31	Q8NA58
QITEFWSRPFKLYLQ	SLITRK3	71	O94933
QFSEIKLLQDFYPWA	PKD1L3	1321	Q7Z443
KLLQDFYPWANHILL	PKD1L3	1326	Q7Z443
LTQKWFPAAINLVYT	TENM1	1066	Q9UKZ4
FSFLPQIDKWLQVAL	SPATA16	166	Q9BXB7
LEATLNWFRLYKVPD	PPA2	231	Q9H2U2
ILLPEKCYDQLFVQW	MPDU1	16	O75352
TIKLNLEITWYPFDV	RIPOR2	306	Q9Y4F9
SKWLNEPNFVSSYDI	SEMA5A	211	Q13591
QSLAEWKLFIYNPTT	ATP1B3	11	P54709
YDLKLPIWANTTEFC	C10orf126	21	Q8N4M7
QFQLLWLCPYKLDLH	NDUFV1-DT	196	Q8NBR9
SKYTLWNFLPKNLFE	ATP11C	51	Q8NB49
PDISFQLIINFDKWS	TECTA	1521	O75443
ILKWELFQLADLDTY	SAV1	321	Q9H4B6
DILLSAYPLSVEWLN	PWP1	181	Q13610
PSWLNINYKVLLVST	TMEM244	56	Q5VVB8
TPEEWALLDTTQKYL	ZNF562	51	Q6V9R5
KAVDLLNYTQWFPIV	TJP2	796	Q9UDY2
FWPEYASSKLLIQVE	VPS13A	2346	Q96RL7
LAPFTKFLIDLYDWT	SLC16A4	161	O15374
LDLKQKFWNTYLSGL	MPV17L	116	Q2QL34
KWSIPAFLYFLDNLI	SLC35A5	96	Q9BS91
NFRDYLWQLIKSALP	SMIM9	56	A6NGZ8
FDYDIALLQLSIAWP	TMPRSS7	691	Q7RTY8
TQTFLLETPEIYWKL	SYCP1	796	Q15431
LEQKYVQLFWGLPSL	SPATA31D1	496	Q6ZQQ2
LTFFYLPTKNLWLLL	TMTC2	271	Q8N394
LPTNLFLLFQEYWDT	UBR1	1546	Q8IWV7
YCDAIKINIFWPLLF	TTC3	81	P53804
LTEPSYELVKSQQWD	TENM3	2431	Q9P273
VAYKDQWEDLTPLTF	ATP6AP1	276	Q15904
LLDNYVSLFEVLLKW	PRKDC	286	P78527
LSLNDFWSSLIQEYP	ZBED5	611	Q49AG3
AVYFSEEEWQLLNPL	ZNF75D	241	P51815
KNNTYWPLVSDFINI	UBR3	506	Q6ZT12
ALAYFEQLKISPDAW	XPOT	21	O43592
LSEIQKDTFWLPFSQ	UGT2B10	96	P36537
PSNFLKTALFLYSWD	TMEM130	166	Q8N3G9
AQIIKEDLWSNPLQY	TSPYL6	366	Q8N831
WYKDILQLIGFANLP	SEMA3G	706	Q9NS98
SKLDGQVWIALYNLL	ZMYND10	256	O75800
IEVLYLWKALPNCSF	TTC39C	451	Q8N584
SLLFHPKQEDWILAY	SORCS1	276	Q8WY21
WTSKYIVIEDPFDLN	TUT7	1271	Q5VYS8
QLWLELLKFYTLDFA	TUT4	631	Q5TAX3
LVSKEAWSKLQQYFP	USP48	666	Q86UV5
GPLQYTIWKSLFQDI	TRIM62	276	Q9BVG3
QNNTPILYTIFSKWD	SLFN5	446	Q08AF3
YLLWVFLPDQDQRSQ	GTF2H3	226	Q13889
TSDFLVLDAQNYPWL	TMEM25	176	Q86YD3
YQLFKPSLISWLEEE	ZNF560	151	Q96MR9
KVDPDSTWFLLNELY	TTI1	1036	O43156
YFLNHIEKITTWQDP	WWTR1	141	Q9GZV5
LYATWTSKLPLEQLN	ZRANB3	991	Q5FWF4